Partner Interview
Published June 10, 2024
Agilon Health: US Physician Enablement Market Dynamics
inpractise.com/articles/agilon-health-us-physician-enablement-market-dynamics
Executive Bio
Former Executive Director at Agilon Health
Interview Transcript
Disclaimer: This interview is for informational purposes only and should not be relied upon as a basis for investment decisions. In Practise is an independent publisher and all opinions expressed by guests are solely their own opinions and do not reflect the opinion of In Practise.
This is a snippet of the transcript.to get full access.
Did the physicians they hired between 2018 and 2019 differ significantly from those they brought on in 2021 and 2022? I'm trying to understand if there's a reason to think that, because they are a relatively young company and didn't hire many physicians in their early days compared to recently, the general performance has worsened. I'm trying to figure out if it's merely environmental or if it could be due to hiring different physicians or something else.
Think about it this way. You could bring on a medical group in a market, say, 50 physicians, who have been a medical group and performed well in a market for a long time, all employed. Your initial relationship in a market might be with that medical group, and because it's a group with some experience and longevity, all the things we've talked about that are markers of higher performance, that first cohort is going to perform pretty well. But then, they look for other opportunities to grow that market with other relationships. Maybe the next one they bring in is a large IPA. Generally, the IPA is not going to perform as well. It doesn't have the leadership structure or the infrastructure. So, that second cohort comes in and performs a lot worse. I think that's what's happening with these guys. They're bringing in different types of organizations into a market, and then they're giving you a medical margin number for that market. The first cohort does well, the second cohort does horribly. It looks like the market is doing worse rather than better. The trick for them is trying to figure out how to bring in cohorts that are performing well to begin with.
Free Sample of 50+ Interviews
Sign up to test our content quality with a free sample of 50+ interviews.
Or contact sales for full access
Related Content

Oscar Health: Entering New Markets & Provider Pain Points
Former Market Manager at Oscar Health

Molina Healthcare: Care Connections Program
Former VP at Molina Healthcare

Centene: Medicaid Margins & Provider Network Challenges
Former VP at Centene Corporation

Elevance Health and ACA Marketplace Dynamics
Former Director at Aetna
© 2024 In Practise. All rights reserved. This material is for informational purposes only and should not be considered as investment advice.